Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of lercanidipine 20 mg tablets in healthy Thai volunteers
TCTR20260827001Phase 1Not yet recruiting
- Sponsor
- International Bio Service
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lercanidipine (2 arms), sponsored by International Bio Service. Primary endpoints: Cmax of S-lercanidipine and R-lercanidipine, AUC0-tlast of S-lercanidipine and R-lercanidipine and 1 more. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
lercanidipine
Beyond the preview
Go deeper on TCTR20260827001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260827001.